Vanguard Capital Management
GOSS icon

Vanguard Capital Management’s Gossamer Bio GOSS Stock Holding History

Vanguard Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
9,416,023
+21,430
+0.2% +$5.98K ﹤0.01% 3494
2026
Q1 		$3.09M Buy
+9,394,593
New +$14.8M ﹤0.01% 3225

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Capital Management's GOSS Position: Q2 2026 in Review

Vanguard Capital Management increased its Gossamer Bio (GOSS) stake by 0.23% in Q2 2026, buying an estimated $5.98K and bringing the position to 9,416,023 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #3494.

Vanguard Capital Management first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.09M in Q1 2026. 155 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Vanguard Capital Management held 9,416,023 shares of Gossamer Bio worth $1.55M as of Q2 2026.
  • Vanguard Capital Management bought 21,430 Gossamer Bio shares in Q2 2026, an estimated $5.98K.
  • Gossamer Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3494 holding.
  • Vanguard Capital Management first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Gossamer Bio position peaked at $3.09M in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.